Chemfab Alkalis Ltd Falls to 52-Week Low Amidst Continued Downtrend

Stock Performance and Market Context

On the day in question, Chemfab Alkalis opened with a gap down of 4.86%, continuing a reversal after two days of consecutive gains. The stock touched an intraday low of Rs.374.95, representing an 8.73% decline from the previous close and underperforming the Commodity Chemicals sector by 6.65%. This decline contributed to a day change of -7.66% for the stock.

Technically, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum. This contrasts with the broader market, where the Sensex, despite a negative close down 0.65% at 81,811.90 points, remains above its 200-day moving average, though below its 50-day average.

While several indices such as NIFTY METAL, NIFTY PSU BANK, and NIFTY PSE reached new 52-week highs on the same day, Chemfab Alkalis’ stock performance remained subdued, reflecting company-specific pressures.

Long-Term Performance and Valuation Metrics

Over the past year, Chemfab Alkalis has delivered a total return of -63.16%, significantly lagging the Sensex’s positive 6.86% return over the same period. The stock’s 52-week high was Rs.1,049.80, underscoring the steep decline to current levels.

The company’s valuation metrics indicate a premium relative to peers, despite subdued financial performance. Its Return on Capital Employed (ROCE) stands at a low 1.8%, while the Enterprise Value to Capital Employed ratio is 1.4, suggesting an expensive valuation given the company’s earnings profile.

Operating profit has contracted at an annualised rate of -6.47% over the last five years, reflecting challenges in sustaining growth. The company’s operating profit to interest coverage ratio for the latest quarter is at a low 0.96 times, indicating limited buffer to service interest expenses.

Recent Financial Results and Profitability Trends

The company has reported negative net profits for two consecutive quarters, with the latest quarter’s Profit After Tax (PAT) at a loss of Rs.4.45 crores, a steep decline of 670.5% compared to the previous four-quarter average. This sharp contraction in profitability has weighed heavily on investor sentiment.

Interest expenses have increased by 26.43% over the last six months to Rs.3.97 crores, further pressuring earnings. Despite a relatively low average debt-to-equity ratio of 0.10 times, the rising interest burden relative to operating profit is a concern.

Over the past year, profits have fallen by 75.8%, compounding the negative return generated by the stock. The company’s market capitalisation grade is rated 4, reflecting its mid-tier size within the Commodity Chemicals sector.

Shareholding and Market Perception

Domestic mutual funds hold a modest stake of only 0.25% in Chemfab Alkalis, which may indicate limited institutional conviction in the stock at current valuations. Given that domestic mutual funds typically conduct thorough research and due diligence, their small holding suggests cautious positioning.

In terms of broader market performance, Chemfab Alkalis has underperformed the BSE500 index over the last three years, one year, and three months, highlighting persistent challenges in delivering shareholder value relative to the wider market.

Summary of Key Concerns

Chemfab Alkalis’ stock has been impacted by a combination of declining profitability, increased interest expenses, and a valuation premium that does not align with its current earnings profile. The stock’s fall to Rs.374.95 represents a new 52-week low, reflecting the cumulative effect of these factors.

The company’s Mojo Score stands at 19.0 with a Mojo Grade of Strong Sell, upgraded from Sell on 7 July 2025, signalling continued caution from rating agencies. The stock’s underperformance relative to sector peers and the broader market indices further emphasises the challenges faced.

Despite a low debt-to-equity ratio, the operating profit to interest coverage ratio below 1 times highlights the tight financial position. The persistent negative quarterly results and significant profit declines over the past year have contributed to the subdued market sentiment.

While the broader market indices have shown resilience, Chemfab Alkalis remains under pressure, with limited institutional support and a valuation that appears stretched given the company’s financial metrics.

Unlock special upgrade rates for a limited period. Start Saving Now →